動画検索
関連広告
検索結果
... and Kathleen N. Moore, MD, outline the clinical evidence for the use of the PARP inhibitor, niraparib, in advanced ovarian cancer.
YouTube-OncLiveTV
2017/02/20動画の見どころ1/5枚目 Three PARP inhibitors: Olaparib, Reparib, and Niraparib
動画の見どころ2/5枚目 Tell us about the NOVA trial
動画の見どころ3/5枚目 Niraparib maintenance treatment improved progression-free survival
動画の見どころ4/5枚目 Do we need a biomarker to direct treatment?
動画の見どころ5/5枚目 Is niraparib very effective in all ovarian cancer patients?
Experts review the PRIMA trial and niraparib's role as maintenance therapy following the frontline management of ovarian cancer.
YouTube-OncLiveTV
2020/07/09動画の見どころ1/8枚目 What is PRIMA?
動画の見どころ2/8枚目 What were the eligibility criteria for this trial?
動画の見どころ3/8枚目 Eligibility criteria for the PRIMA trial
動画の見どころ4/8枚目 Primary endpoint
動画の見どころ5/8枚目 Subgroup analyses
動画の見どころ6/8枚目 BRCA1 vs BRCA2
動画の見どころ7/8枚目 Safety signals
動画の見どころ8/8枚目 What does this mean for clinical practice?
Mansoor Mirza, MD of Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark discusses clinical trials in ovarian cancer in ...
YouTube-VJOncology
2016/10/18Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer ...
YouTube-OncLiveTV
2018/03/05Michael J. Birrer, MD, PhD, reviews the personalized dosing for niraparib in the PRIMA study, and monitoring platelet counts.
YouTube-OncLiveTV
2020/08/14No photo description available. European Cancer Organisation. European Cancer Or...
Facebook-The ASCO Post
2022/03/08DR BIRRER: There're some subtle differences. Rucaparib, it looks to me like the anemia is a little higher than the other two. And for niraparib, ...
Research To Practice
2017/01/25On www.xtalks.com - The US Food and Drug Administration (FDA) has approved Zejula (niraparib) as a maintenance treatment for women with ...
YouTube-Xtalks Webinars
2017/04/04Evaluación de la efectividad, seguridad y adherencia en pacientes tratadas con niraparib . ✓ Presenta: Ana María Ramírez ...
YouTube-Instituto de Investigación Sanitaria de Alicante
2023/09/25C'è una novità importante per le donne italiane che hanno ricevuto una diagnosi di tumore dell'ovaio. L'Agenzia italiana del farmaco (Aifa), ...
YouTube-PharmaStarTV
2021/12/10https://www.medicinaeinformazione.com/ https://www.facebook.com/MedicinaEInformazione https://twitter.com/EInformazione CARCINOMA OVARICO: ...
YouTube-MedicinaInformazione
2021/12/14臨床卵巢癌治療上雖然有一些突破，但是仍然有一些重大的關卡未解。 這些重大的關卡是什麼? 卵巢癌的治療之後，即便在手術化學治療之後， ...
YouTube-與您癌歸於好
2022/10/06... niraparib於第一線維持治療， ... #卵巢癌 #BRCA #PARP #標靶治療 #olaparib #niraparib #2023ESMO #歐洲 ...
YouTube-與您癌歸於好
2024/01/16DNA修復酵素PARPを阻害する薬ルカパリブが、BRCA1、BRCA2、PALB2遺伝子変異陽性の膵癌に対する維持療法として、安全かつ有効であることが第2相臨床 ...
YouTube-がん情報チャンネル・外科医 佐藤のりひろ
2021/06/02... niraparib #Lynparza #令癌莎膜衣錠 #ProFound #陳駿逸醫師 #與你癌歸於好 #台中市全方位癌症關懷協會 更多陳駿逸醫師的癌症衛教影片請連接https ...
YouTube-與您癌歸於好
2024/01/22... Niraparib(截永樂/Zejula). 34:01. 如何使用PARP標靶藥物作維持治療，好讓卵巢癌 ... #Niraparib. 更多陳駿逸醫師的癌症衛教影片請連接https://mycancerfree.com/videos ...
陳駿逸醫師與你癌歸於好-與您癌歸於好
2022/12/21求める情報が見つからない場合は、キーワードや指定した条件を変えてみてください。